bluebird bio Inc. (NASDAQ: BLUE)
$1.35
+0.0300 ( +2.27% ) 1.7M
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Market Data
Open
$1.35
Previous close
$1.32
Volume
1.7M
Market cap
$182.68M
Day range
$1.31 - $1.36
52 week range
$0.85 - $5.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 03, 2024 |
8-k | 8K-related | 14 | Apr 26, 2024 |
8-k | 8K-related | 13 | Apr 16, 2024 |
8-k | 8K-related | 15 | Mar 26, 2024 |
nt | Quarterly Reports | 1 | Mar 26, 2024 |
8-k | 8K-related | 13 | Mar 18, 2024 |
4 | Insider transactions | 2 | Mar 05, 2024 |
4 | Insider transactions | 2 | Mar 05, 2024 |
4 | Insider transactions | 2 | Mar 05, 2024 |
4 | Insider transactions | 2 | Mar 05, 2024 |